Literature DB >> 1934412

Repair of tetralogy of Fallot in infancy. Effect of pulmonary artery size on outcome.

M A Groh1, J N Meliones, E L Bove, J W Kirklin, E H Blackstone, F M Lupinetti, A R Snider, A Rosenthal.   

Abstract

The possible influence of small pulmonary artery size on the results following complete repair of tetralogy of Fallot has not been investigated in patients less than 1 year of age. We, therefore, reviewed our recent experience with infant repair to assess this. Between January 87 and October 90, repair was performed in 58 infants less than 1 year old (median, 6 months) with tetralogy of Fallot and pulmonary stenosis (n = 53) or pulmonary atresia without important aortopulmonary collaterals (n = 5). The McGoon ratio (diameter of the right pulmonary artery at the prebranching point plus that of the left divided by the diameter of the aorta at the diaphragm) by cineangiography (n = 48) was between 1.2 and 1.5 in 15 patients, 1.6 and 2.0 in 20, and greater than 2.0 in 13. Transannular patching was performed in 19 of the patients with pulmonary stenosis (36%). Muscle resection was avoided in 29 infants and was minimal in the remaining 29. A weak correlation, with considerable scatter, was found between the McGoon ratio and postrepair right ventricular/left ventricular pressure measured in the operating room (r = 0.4), and the relations were similar to those previously reported for children. Right ventricular/left ventricular pressure was 0.55 +/- 0.03 in infants with McGoon ratios of 1.2-1.5, 0.46 +/- 0.03 with ratios of 1.6-2.0, and 0.47 +/- 0.03 with ratios greater than 2.0 (p = 0.01). There were no hospital deaths, and the 3-year survivorship was 94%. Two infants underwent successful reoperation for residual right ventricular outflow tract obstruction. All other patients are free of significant hemodynamic residua.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1934412

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Tetralogy of Fallot.

Authors:  Samantha C. Gouw; Thuy-Nga Le; Narayanswami Sreeram
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

2.  Surgical correction of tetralogy of Fallot in a 61-year-old patient.

Authors:  Hideki Tsubota; Tomohiro Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-15

3.  4D Flow MRI Estimation of Boundary Conditions for Patient Specific Cardiovascular Simulation.

Authors:  Ryan Pewowaruk; Alejandro Roldán-Alzate
Journal:  Ann Biomed Eng       Date:  2019-05-08       Impact factor: 3.934

4.  Risk factors for morbidity in infants undergoing tetralogy of fallot repair.

Authors:  Alexander C Egbe; Alexander J Mittnacht; Khanh Nguyen; Umesh Joashi
Journal:  Ann Pediatr Cardiol       Date:  2014-01

5.  Predictors of Intensive Care Unit Morbidity and Midterm Follow-up after Primary Repair of Tetralogy of Fallot.

Authors:  Alexander C Egbe; Khanh Nguyen; Alexander Jc Mittnacht; Umesh Joashi
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-06-05

6.  Predictors of Length of Hospital Stay After Complete Repair for Tetralogy of Fallot: A Prospective Cohort Study.

Authors:  Laura Mercer-Rosa; Okan U Elci; Grace DeCost; Stacy Woyciechowski; Sharon M Edman; Chitra Ravishankar; Christopher E Mascio; Steven M Kawut; Elizabeth Goldmuntz
Journal:  J Am Heart Assoc       Date:  2018-05-16       Impact factor: 5.501

7.  Stent interventions for pulmonary artery stenosis improve bi-ventricular flow efficiency in a swine model.

Authors:  Ryan J Pewowaruk; Gregory P Barton; Cody Johnson; J Carter Ralphe; Christopher J Francois; Luke Lamers; Alejandro Roldán-Alzate
Journal:  J Cardiovasc Magn Reson       Date:  2021-02-25       Impact factor: 5.364

8.  Pulmonary Vein Index Is Associated With Early Prognosis of Surgical Treatment for Tetralogy of Fallot.

Authors:  Haoyong Yuan; Tao Qian; Ting Huang; Hui Yang; Can Huang; Ting Lu; Zhongshi Wu
Journal:  Front Pediatr       Date:  2021-07-12       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.